OACCNasdaqBlank ChecksFiscal year ends December 31Also trades as OACCU, OACCW
Oaktree Acquisition Corp. III Life Sciences
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$10.65−0.05 (-0.47%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
Oaktree Acquisition Corp. III Life Sciences has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements Oaktree Acquisition Corp. III Life Sciences filed with the SEC
Oaktree Acquisition Corp. III Life Sciences Announces the Separate Trading of its Class A Ordinary Shares
Other events · EX-99.1 to Form 8-K
OAKTREE ACQUISITION CORP. III LIFE SCIENCES
Unregistered share sale · Other events · EX-99.1 to Form 8-K
OAKTREE ACQUISITION CORP. III LIFE SCIENCES
Other events · EX-99.1 to Form 8-K
Oaktree Acquisition Corp. III Life Sciences Announces Pricing of
Material agreement · Unregistered share sale · Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K